Literature DB >> 70614

Cholera and blood-groups.

A Chaudhuri, S De.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 70614     DOI： 10.1016/s0140-6736(77)90332-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Cholera: foodborne transmission and its prevention.

Authors:  T Estrada-García; E D Mintz
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

2.  An overview of VaxchoraTM, a live attenuated oral cholera vaccine.

Authors:  Tarun Saluja; Vijayalaxmi V Mogasale; Jean-Louis Excler; Jerome H Kim; Vittal Mogasale
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

3.  Binding of cholera toxin to pig intestinal mucosa glycosphingolipids: relationship with the ABO blood group system.

Authors:  F R Bennun; G A Roth; C G Monferran; F A Cumar
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections.

Authors:  Andrea Rinaldo; Enrico Bertuzzo; Lorenzo Mari; Lorenzo Righetto; Melanie Blokesch; Marino Gatto; Renato Casagrandi; Megan Murray; Silvan M Vesenbeckh; Ignacio Rodriguez-Iturbe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-13       Impact factor: 11.205

Review 5.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Inhibition of cholera toxin binding to membrane receptors by pig gastric mucin-derived glycopeptides: differential effect depending on the ABO blood group antigenic determinants.

Authors:  C G Monferran; G A Roth; F A Cumar
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

Review 7.  Travellers' diarrhoea: contemporary approaches to therapy and prevention.

Authors:  Herbert L DuPont
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.

Authors:  Wilbur H Chen; Mitchell B Cohen; Beth D Kirkpatrick; Rebecca C Brady; David Galloway; Marc Gurwith; Robert H Hall; Robert A Kessler; Michael Lock; Douglas Haney; Caroline E Lyon; Marcela F Pasetti; Jakub K Simon; Flora Szabo; Sharon Tennant; Myron M Levine
Journal:  Clin Infect Dis       Date:  2016-03-21       Impact factor: 9.079

9.  Interaction of cholera toxin and Escherichia coli heat-labile enterotoxin with glycoconjugates from rabbit intestinal brush border membranes: relationship with ABH blood group determinants.

Authors:  L E Balanzino; J L Barra; E M Galván; G A Roth; C G Monferran
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

10.  Escherichia coli heat-labile enterotoxin preferentially interacts with blood group A-active glycolipids from pig intestinal mucosa and A- and B-active glycolipids from human red cells compared to H-active glycolipids.

Authors:  J L Barra; C G Monferran; L E Balanzino; F A Cumar
Journal:  Mol Cell Biochem       Date:  1992-09-22       Impact factor: 3.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.